Prostate cancer — all decisions

The Board granted service connection for prostate cancer, resolving reasonable doubt in the Veteran's favor.

The Board remands the Veteran's claim for service connection for prostate cancer to obtain an addendum opinion addressing his exposure to ionizing radiation.

The Board denied service connection for diabetes mellitus type II, prostate cancer, and peripheral neuropathy in the right and left upper and lower extremities as there was no evidence of an in-service injury or disease related to these conditions.

The Board denied initial compensable ratings for squamous cell carcinoma and prostate cancer, finding that the Veteran's conditions did not meet the criteria for a compensable rating.

The Board remands the claims for an earlier effective date for service connection and a higher initial rating due to inadequate medical opinions.

The Board granted service connection for prostate cancer, a radiogenic disease, due to the Veteran's exposure to ionizing radiation during active-duty service.

The Board denied service connection for a right ankle disability, left ankle disability, and prostate cancer as the evidence did not support a finding of current disabilities or a link to in-service injuries or exposures.

The Veteran's service connection for right ankle pain was granted, while his claims for ED and prostate cancer were denied.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability due to his service-connected prostate cancer and erectile dysfunction, as these conditions do not prevent him from securing or following substantially gainful employment.

The Board remands the claims for service connection for diabetes mellitus type II, hypertension, bilateral upper extremity neuropathy, bilateral lower extremity neuropathy, and prostate cancer due to duty to assist errors.

The Board granted service connection for prostate cancer and denied service connection for fatty liver disease. The issues related to pelvic metastasis with hip pain and chronic back pain were remanded.

The Board denied service connection for prostate cancer and metastatic cancer to the bone, finding no evidence of in-service exposure to herbicides or a direct link between the cancers and the Veteran's military service.

The Board remands the claims for service connection due to a pre-decisional duty to assist error, as the November 2023 TERA opinions are inadequate.

The Board remands the claim for service connection for prostate cancer to obtain an adequate medical opinion on its etiology, particularly in light of new evidence of conceded toxic chemical exposures.

The Board granted service connection for prostate cancer but dismissed the claims for an increased rating for left ear hearing loss and service connection for right ear hearing loss due to a pre-decisional duty-to-assist error.

The Board granted service connection for prostate cancer, finding a link to the Veteran's in-service exposure to contaminated water at Camp Lejeune.

The Veteran's service-connected PTSD was granted a rating of 70 percent, but no greater, for the period on appeal prior to December 31, 2020. The claim for an increased rating in excess of 60 percent for residuals of prostate cancer was denied.

The Board remands the claim for a new VA examination to provide an opinion on whether the Veteran's prostate cancer is related to service, including exposure to chemicals in association with his military duties.

The Board remands the claims for a higher rating for respiratory conditions and service connection for kidney, prostate, bladder cancer, and obstructive sleep apnea due to outstanding medical records and inadequate VA opinions.

The proposed rating reduction for prostate cancer, which is currently rated as 100 percent disabling, was dismissed because the appeal was filed prematurely.